Weight loss drug fill rates

Demand for weight loss drugs is rising, though many insurers won’t cover them
These weight loss drugs are expensive out of pocket, though. Even with insurance, high co-pays can also limit who has access to them.
Pricey weight loss drugs lose some disciples in 2024
People struggling with their body weight experienced joy when new, more effective prescription drug options became the rage in 2023, but it seems many folks stopped taking them in 2024.
Is Zepbound or Wegovy Better for Weight Loss? One Can Help You Shed 50 Lbs
With so many weight loss medications on the market, it’s easy to feel overwhelmed by the options. From brand-name heavy hitters to compounded varieties, each promises to help shed pounds. But a recent head-to-head trial comparing Zepbound vs.
Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly.
Which Weight-Loss Drug Is Better: Wegovy or Zepbound?
W ith more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more effective? In a press release, Lilly announced that in its la
Zepbound brings more weight loss than Wegovy: Drugmaker
Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical trial results. Zepound manufacturer Eli Lilly released results from their SURMOUNT-5 phase clinical trial on Wednesday which is the first time both GLP1s have been compared side-by-side.
Lilly's Zepbound tops Wegovy for weight loss in head-to-head trial
Eli Lilly said on Wednesday patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in the first large, head-to-head trial of the highly in-demand rival medicines.
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to new data released Wednesday by Eli Lilly, the maker of Zepbound.
Weed and Weight Loss?
Cannabis might help with weight loss by targeting the endocannabinoid system, potentially suppressing appetite, boosting metabolism, and offering new, less invasive treatments for obesity and
Zepbound Vs. Wegovy: Which Is Better for Weight Loss?
For the uninitiated, both Zepbound (tirzepatide) and Wegovy (semaglutide) are weight loss drugs. They target hormones that influence metabolism and appetite, but they operate through different mechanisms.
Weight loss drug fill rates, by state
To assess state-level trends, GoodRx examined fill rates for all medications, excluding vaccines, from a nationally representative sample between Jan. 1 and Oct. 31. The figures below reflect the percentage of total medication fills for GIP and GLP-1 drugs prescribed for either diabetes or weight loss indications.
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
It is made possible through a first-of-a-kind integration with Eli Lilly's direct-to-consumer website, and aims to streamline ...
West Virginia’s Weight-Loss Experiment
For the state, the cost of funding GLP-1 drugs was too high. For the patients, the cost of losing access is higher.
Fierce Healthcare8h
Ro teams up with Eli Lilly to offer single-dose vials of weight loss drug Zepbound
Direct-to-consumer health and wellness company Ro will now offer access to lower-priced, single-dose vials of weight loss ...
Zepbound users discuss weight loss after preliminary research touts effectiveness
A preliminary study on popular weight loss drugs finds participants shed more weight on Zepbound than on Novo Nordisk’s ...